Skip to main navigation Skip to search Skip to main content

Correction to: Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer (British Journal of Cancer, (2025), 133, 2, (208-215), 10.1038/s41416-025-03052-y)

  • Keun Wook Lee
  • , Dae Young Zang
  • , Hyung Don Kim
  • , Jin Won Kim
  • , Bum Jun Kim
  • , Yoon Koo Kang
  • , Min Hee Ryu
  • , Hark Kyun Kim

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Correction to: Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer (British Journal of Cancer, (2025), 133, 2, (208-215), 10.1038/s41416-025-03052-y)'. Together they form a unique fingerprint.
Sort by

Nursing and Health Professions

Keyphrases

Medicine and Dentistry